| Financial Year |
March 31 2023 |
| Monetary Funds |
506,362,197.51 |
| Held-for-trading Financial Assets |
50,000,000.00 |
| Notes Receivable |
365,349,231.56 |
| Accounts Receivable |
742,682,324.65 |
| Advances to Suppliers |
23,441,337.87 |
| Other Receivables |
27,352,461.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,631,660.97 |
| Dividend Receivable |
-- |
| Inventories |
409,385,276.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
180,759,756.18 |
| Total Current Assets |
2,389,677,928.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
71,366,981.84 |
| Investment Properties |
-- |
| Fixed Assetes |
799,338,718.50 |
| Under-construction Projects |
235,869,475.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
116,785,091.51 |
| R&D expenses |
-- |
| Goodwill |
37,248,703.53 |
| Long-Term Deferred and Prepaid Expenses |
2,253,818.88 |
| Deferred Income Tax Assets |
48,794,319.34 |
| Other Non-Current Assets |
38,806,953.28 |
| Sub-Total of Non-Current Assets |
1,396,043,778.12 |
| Total Assets |
3,785,721,706.28 |
| Short-Term Loans |
483,150,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
328,822,152.92 |
| Accounts Payable |
851,954,952.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
31,395,475.59 |
| Taxes Payable |
16,203,552.52 |
| Interest Payable |
154,422.56 |
| Dividend Payable |
-- |
| Other payables |
53,315,886.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,003,042.21 |
| Other Current Liabilities |
121,512,889.76 |
| Sub-Total of Current Liabilities |
1,902,033,350.75 |
| Long-term Loans |
6,199,200.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
31,773,477.85 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
74,525,091.05 |
| Total Liabilities |
1,976,558,441.80 |
| Paid-In Capital(Or Share Stock) |
301,946,455.00 |
| Capital Surplus |
878,533,451.29 |
| Surplus Reserve |
129,179,351.51 |
| LESS:Treasury Stock |
22,380,000.00 |
| Undistributed Profits |
522,630,279.34 |
| Minority Stockholder's Interest |
1,625,672.76 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,807,537,591.72 |
| Owner's Equity（Stockholder's Equity） |
1,809,163,264.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,785,721,706.28 |
